Filing Details

Accession Number:
0001179110-14-004511
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-05 16:42:07
Reporting Period:
2014-03-03
Filing Date:
2014-03-05
Accepted Time:
2014-03-05 16:42:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203301 W Myron Wentz 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-03 15,407 $26.06 6,589,574 No 4 M Indirect Shares owned of record by Gull Holdings
Common Stock Disposition 2014-03-03 15,407 $72.06 6,574,167 No 4 S Indirect Shares owned of record by Gull Holdings
Common Stock Acquisiton 2014-03-04 48,398 $26.06 6,622,565 No 4 M Indirect Shares owned of record by Gull Holdings
Common Stock Disposition 2014-03-04 48,398 $72.90 6,574,167 No 4 S Indirect Shares owned of record by Gull Holdings
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Shares owned of record by Gull Holdings
No 4 S Indirect Shares owned of record by Gull Holdings
No 4 M Indirect Shares owned of record by Gull Holdings
No 4 S Indirect Shares owned of record by Gull Holdings
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2014-03-03 24,147 $0.00 24,147 $26.06
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2014-03-04 75,853 $0.00 75,853 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,853 2009-07-21 2014-01-21 No 4 M Direct
0 2009-07-21 2014-01-21 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
  2. Average Price. Price range was $72.00 to $72.30.
  3. Average Price. Price range was $72.05 to $73.70.